Palette Media Raises $3.5M Pre-Seed Round

INNOVOTEX INC.

INNOVOTEX is a pharmaceutical company advancing Macrocycle Drug Conjugates (MDCs), a novel therapeutic platform designed to improve tumor localization, retention, and intracellular delivery. Its lead candidate, NOVO-111, is being developed to address persistent limitations in oncology through enhanced therapeutic exposure and durability.

Remedium Bio

Remedium Bio is a gene therapy company focused on the development of treatments for large unmet clinical needs. To enable this, we developed a revolutionary gene therapy platform technology, which enables safe, effective, and durable delivery of therapeutic genes while allowing for simple post-treatment dose adjustment. The Prometheus™ adjustable gene therapy platform is able to safely and durably replace multi-injection subcutaneously administered biologics, with a single treatment, at a fraction of the cost, and without genetic integration. Our lead product is a disease-modifying treatment for Osteoarthritis that is based on the only clinically validated chondro-regenerative mechanism. Remedium’s pipeline includes gene therapy treatments in the fields of Weight Loss, Type 2 Diabetes, and Stroke.